Lakefront Biotherapeutics | GLPG - 贸易债权人





贸易债权人 更改 日
argenx SE USD 554.27M 297.94M 2025-12
AstraZeneca USD 22.51B 2.78B 2026-03
Biogen USD 358.5M 73.5M 2026-03
Genmab DKK 6M 2M 2025-09
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Merck EUR 2.13B 19M 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.32B 134M 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
UCB EUR 4.04B 755M 2025-12
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03